Acadia Healthcare Company, INC Form 4 insider transactions

Brian Farley, EVP, CLAO and Secretary of Acadia Healthcare Company, Inc., reported a transaction in 1,770 shares of common stock on July 26, 2026.

Acadia Healthcare Company, Inc. reports a transaction where EVP, CLAO and Secretary Brian Farley sold 1,370 shares of common stock.

Director Michael Fucci acquired 6,331 shares of Acadia Healthcare Company, Inc. common stock as part of an equity grant.

Director Ralph David Kelly acquired 6,331 shares of Acadia Healthcare Company, Inc. common stock as part of an equity grant.

Acadia Healthcare Company, Inc. director Vicky B. Gregg was granted 6,331 shares of common stock as part of a compensation arrangement.

Director Jason Bernhard acquired 11,455 shares of Acadia Healthcare common stock through equity grants and retainer elections.

Acadia Healthcare director William Grieco was granted 6,331 shares of common stock as part of an equity compensation plan.

Acadia Healthcare Company, Inc. director Daniel J. Cancelmi was granted 6,331 shares of common stock as part of a compensation arrangement.

Acadia Healthcare Company, Inc. director Patrice A. Harris acquired 6,331 shares of common stock via an equity grant.

Director Reeve B. Waud acquired 15,907 shares of Acadia Healthcare common stock through equity grants and a retainer election.

Director E. Perot Bissell acquired 11,831 shares of Acadia Healthcare Company, Inc. through equity grants and a retainer election.

Brian Farley, EVP, CLAO and Secretary of Acadia Healthcare, disposed of 5,063 shares of common stock to cover tax obligations.

Brian Farley, EVP, CLAO and Secretary of Acadia Healthcare, was granted 37,510 shares of common stock.

Acadia Healthcare Company, Inc. reports that Chief Financial Officer Todd S. Young acquired 58,799 shares of common stock on April 10, 2026, as part of a vesting plan.

Acadia Healthcare Company, Inc. executive Brian Farley reported the acquisition of 37,510 shares of common stock.

Acadia Healthcare Company Director Daniel J. Cancelmi was granted 6,625 shares of common stock, vesting over a three-year period.

Acadia Healthcare's EVP, GC, and Secretary, Brian Farley, disposed of 1,915 shares of common stock to cover tax withholding obligations.

Acadia Healthcare's CEO, Debra K. Osteen, was granted 1.125 million performance-based stock options with a $11.68 exercise price, vesting upon specific share price targets.

Acadia Healthcare's Chief Financial Officer, Todd S. Young, acquired 48,445 shares of common stock as part of a compensation plan, vesting over three years.

Acadia Healthcare's Chief Operating Officer, Nasser Khan, disposed of 973 common shares to cover tax withholding obligations.

Acadia Healthcare's Chief Financial Officer, Heather Brianne Dixon, reported the disposition of 2,410 shares of common stock at $21.74 per share, primarily to cover tax withholding obligations, effective July 25, 2025.

Acadia Healthcare Company, Inc. EVP, GC and Secretary Brian Farley reported the future disposition of 1,095 shares of common stock.

Acadia Healthcare Company, Inc. CEO Christopher H. Hunter reported the disposition of 5,464 shares of common stock on June 26, 2025, at $20.94 per share, primarily to satisfy tax withholding obligations.

Acadia Healthcare Company, Inc.'s Chief Financial Officer, Heather Brianne Dixon, reported the disposition of 1,508 shares of common stock to satisfy tax withholding obligations.

Acadia Healthcare Company, Inc. EVP, GC and Secretary Brian Farley disposed of 847 shares of common stock to cover tax withholding obligations.

Acadia Healthcare Company, Inc. Director E. Perot Bissell acquired 7,032 shares of common stock on May 29, 2025, as part of a compensation grant with a three-year vesting schedule.

Acadia Healthcare Company, Inc. Director Wade D. Miquelon has acquired 7,032 shares of common stock through a grant, increasing his beneficial ownership to 55,520 shares, with the new shares vesting over three years.

Acadia Healthcare Company, Inc. Director Vicky B. Gregg was granted 7,032 shares of common stock, which will vest over a three-year period.

Acadia Healthcare Company, Inc. Director and 10% owner Reeve B. Waud has increased his beneficial ownership in the company through recent stock acquisitions, including shares received as compensation.

Acadia Healthcare Company, Inc. Director William Grieco has increased his direct beneficial ownership of common stock by acquiring 11,427 shares through a combination of stock awards and conversion of his 2025 annual cash retainer.